DrugPatentWatch Database Preview
Details for Biologics License Application: 125249
Try a free trial
See Plans and Pricing
Summary for BLA: 125249
| Tradename: | ARCALYST |
| Applicant: | Regeneron Pharmaceuticals |
| Ingredient: | rilonacept |
| Patents: | 21 |
| Approval Date: | Feb 27, 2008 |
| Suppliers: see list | 1 |
US Patents for BLA: 125249
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals | ARCALYST | rilonacept | VIAL; SINGLE-USE | 125249 | 001 | 2008-02-27 | Try a Free Trial | The Children\'s Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA) | 2034-04-21 | RX | Orphan | search |
| Regeneron Pharmaceuticals | ARCALYST | rilonacept | VIAL; SINGLE-USE | 125249 | 001 | 2008-02-27 | Try a Free Trial | Occlugel (Jouy en Josas, FR) Centre National de la Recherche Scientifique (CNRS) (Paris, FR) Assistance Publique Hopitaux de Paris (Paris, FR) Universite Paris Diderot--Paris 7 (Paris, FR) | 2031-03-09 | RX | Orphan | search |
| Regeneron Pharmaceuticals | ARCALYST | rilonacept | VIAL; SINGLE-USE | 125249 | 001 | 2008-02-27 | Try a Free Trial | Laureate Institute For Brain Research (Tulsa, OK) | 2034-12-04 | RX | Orphan | search |
| Regeneron Pharmaceuticals | ARCALYST | rilonacept | VIAL; SINGLE-USE | 125249 | 001 | 2008-02-27 | Try a Free Trial | CardioForecast Ltd. (London, GB) | 2037-01-12 | RX | Orphan | search |
| Regeneron Pharmaceuticals | ARCALYST | rilonacept | VIAL; SINGLE-USE | 125249 | 001 | 2008-02-27 | Try a Free Trial | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) | 2013-10-20 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
